HGC Investment Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

HGC Investment Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,503	Closed	-$2K	–	194
2020 Q3	$2K	Hold	5,503	–	–	﹤0.01%	137
2020 Q2	$3K	Hold	5,503	–	–	﹤0.01%	116
2020 Q1	$0	Hold	5,503	–	–	﹤0.01%	118
2019 Q4	$1K	Hold	5,503	–	–	﹤0.01%	98
2019 Q3	$1K	Hold	5,503	–	–	﹤0.01%	121
2019 Q2	$2K	Buy	+5,503	New	+$973	﹤0.01%	114
2018 Q1	–	Sell	-9,962	Closed	-$4K	–	58
2017 Q4	$4K	Buy	+9,962	New	+$3.8K	﹤0.01%	72

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

HGC Investment Management's NRXPW Position: Q4 2020 in Review

HGC Investment Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 5,503 shares — an estimated $2K sold.

HGC Investment Management first reported a position in NRXPW in Q4 2017 and held it in 7 quarters. The position peaked at $4K in Q4 2017. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

HGC Investment Management reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
HGC Investment Management sold 5,503 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $2K.
HGC Investment Management first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 7 quarters.
HGC Investment Management's NRX Pharmaceuticals Warrant position peaked at $4K in Q4 2017.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on HGC Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.